A three-part study explored the basis for an interaction between changes in
thyroid status and bulbospinal serotonin (5HT) metabolism. In experiment 1
, three well-characterized models of primary hypothyroidism were all accomp
anied by significant increases in 5HT metabolism. In experiment 2, circulat
ing thyroid hormone levels were experimentally varied from very low methima
zole (Meth) treatment to very high (T-3 implants: 2.5, 5.0, or 7.5 mg triio
dothyronine). As ia experiment 1, Meth led to elevated 5HT. Hyperthyroidism
was accompanied by significant reductions in 5HT, while urinary norepineph
rine excretion paralleled 5HT. In experiment 3, rats were subjected to Meth
either 2 weeks before or after induction of diabetes with streptozotocin (
Stz). Meth prevented Stz-associated reductions in 5HT and attenuated develo
pment of hyperphagia. Meth could not reverse established Stz-associated red
uction in 5HT or hyperphagia, although both were slightly attenuated. Thus,
although the first two experiments argue for a simple inverse relationship
between circulating thyroid hormone levels and 5HT in the brain, experimen
t 3 demonstrated that Stz-associated decrements in 5HT could not be reverse
d by subsequent lowering of circulating thyroid hormone. Nor did accompanyi
ng measurements indicate that glycemic status or circulating levels of lept
in were important predictors of 5HT. Thus the interaction between thyroid h
ormones and 5HT is both more subtle and more complex than previously though
t.